View of COMBINATION THERAPY WITH ROSUVASTATIN AND EZETIMIBE (TREZETE) IN VERY HIGH CARDIOVASCULAR RISK DYSLIPIDEMIA: EVIDENCE OF EFFICACY AND CLINICAL IMPACT

Return to Article Details COMBINATION THERAPY WITH ROSUVASTATIN AND EZETIMIBE (TREZETE) IN VERY HIGH CARDIOVASCULAR RISK DYSLIPIDEMIA: EVIDENCE OF EFFICACY AND CLINICAL IMPACT Download Download PDF